27
Publications
4.8K
Citations
21
H-Index
1988
Active since
Karl Nocka is an author at Pfizer (United States) specializing in medicine, immunology, and cell biology.
Top concepts
MedicineImmunologyAllergyCell BiologyInflammationPharmacologyCell SignalingLung InflammationInflammatory Lung DiseaseAsthma
Publications per year
1988–2023
27
27
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Berkley A. Lynch, Nathalie Lambeng, Karl Nocka et al. · Proceedings of the National Academy of Sciences · 2004 · 1.6K citations · Full text
New Antiepileptic Drug, Molecular Neuroscience, Antiepileptic Drug Levetiracetam +15
Gonadal expression of <i>c-kit</i> encoded at the W locus of the mouse
Katya Manova, Karl Nocka, Peter Besmer et al. · Development · 1990 · 480 citations
Paul V. Fish, P. Filippakopoulos, Gerwyn Bish et al. · Journal of Medicinal Chemistry · 2012 · 195 citations · Full text
Histone Modifications, Pharmaceutical Science, Drug Target +20
Rows per page
1–5 of 27